Cargando…

Detection of the Safe Zone for Upper Eyelid Hyaluronic Acid Injections

BACKGROUND: Hyaluronic acid (HA) injections for upper eyelid volumisation are safe procedures with short downtime and low complication rates. Nevertheless, the upper eyelid is a high-risk area for vascular complications because of its rich vascular network. After injection, bruising, an indicator of...

Descripción completa

Detalles Bibliográficos
Autores principales: Can, Bilgen, BetülGözel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455111/
https://www.ncbi.nlm.nih.gov/pubmed/36092216
http://dx.doi.org/10.4103/ijd.ijd_787_21
_version_ 1784785512427421696
author Can, Bilgen
BetülGözel,
author_facet Can, Bilgen
BetülGözel,
author_sort Can, Bilgen
collection PubMed
description BACKGROUND: Hyaluronic acid (HA) injections for upper eyelid volumisation are safe procedures with short downtime and low complication rates. Nevertheless, the upper eyelid is a high-risk area for vascular complications because of its rich vascular network. After injection, bruising, an indicator of vascular penetration, develops very often and prolongs the short downtime. AIMS: To describe a pain-controlled withdrawal technique for minimizing vascular complications and to examine the effects of topical anaesthesia administered prior to injection on complications related to vascular penetration. METHODS: HA was injected into the upper eyelids of 25 patients using the pain-controlled withdrawal technique without topical anaesthesia. The patients’ median age, complication rates, average amount of HA administered, and follow-up periods were evaluated. In addition, the patients were asked to evaluate their pain during injection using a numerical pain rating scale. RESULTS: The patients’ mean age was 40.4 ± 7.3 years. Minimal eyelid edema developed in all patients but did not prevent any of the patients’ social activities. No bruising was detected in any of the patients, and no major vascular complications, such as blindness or cerebrovascular events, developed. The average amount of HA administered was 1.43 ± 0.45 cc. All patients evaluated their pain during injection as mild. CONCLUSIONS: With the pain-controlled withdrawal technique, none of the patients had minor or major complications due to vascular penetration. The procedure was well tolerated by the patients. The detection of the safe injection zone allowed the administration of more than the standard/accepted 01 cc HA (up to 0.3 cc) from one point.
format Online
Article
Text
id pubmed-9455111
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-94551112022-09-09 Detection of the Safe Zone for Upper Eyelid Hyaluronic Acid Injections Can, Bilgen BetülGözel, Indian J Dermatol Original Article BACKGROUND: Hyaluronic acid (HA) injections for upper eyelid volumisation are safe procedures with short downtime and low complication rates. Nevertheless, the upper eyelid is a high-risk area for vascular complications because of its rich vascular network. After injection, bruising, an indicator of vascular penetration, develops very often and prolongs the short downtime. AIMS: To describe a pain-controlled withdrawal technique for minimizing vascular complications and to examine the effects of topical anaesthesia administered prior to injection on complications related to vascular penetration. METHODS: HA was injected into the upper eyelids of 25 patients using the pain-controlled withdrawal technique without topical anaesthesia. The patients’ median age, complication rates, average amount of HA administered, and follow-up periods were evaluated. In addition, the patients were asked to evaluate their pain during injection using a numerical pain rating scale. RESULTS: The patients’ mean age was 40.4 ± 7.3 years. Minimal eyelid edema developed in all patients but did not prevent any of the patients’ social activities. No bruising was detected in any of the patients, and no major vascular complications, such as blindness or cerebrovascular events, developed. The average amount of HA administered was 1.43 ± 0.45 cc. All patients evaluated their pain during injection as mild. CONCLUSIONS: With the pain-controlled withdrawal technique, none of the patients had minor or major complications due to vascular penetration. The procedure was well tolerated by the patients. The detection of the safe injection zone allowed the administration of more than the standard/accepted 01 cc HA (up to 0.3 cc) from one point. Wolters Kluwer - Medknow 2022 /pmc/articles/PMC9455111/ /pubmed/36092216 http://dx.doi.org/10.4103/ijd.ijd_787_21 Text en Copyright: © 2022 Indian Journal of Dermatology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Can, Bilgen
BetülGözel,
Detection of the Safe Zone for Upper Eyelid Hyaluronic Acid Injections
title Detection of the Safe Zone for Upper Eyelid Hyaluronic Acid Injections
title_full Detection of the Safe Zone for Upper Eyelid Hyaluronic Acid Injections
title_fullStr Detection of the Safe Zone for Upper Eyelid Hyaluronic Acid Injections
title_full_unstemmed Detection of the Safe Zone for Upper Eyelid Hyaluronic Acid Injections
title_short Detection of the Safe Zone for Upper Eyelid Hyaluronic Acid Injections
title_sort detection of the safe zone for upper eyelid hyaluronic acid injections
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455111/
https://www.ncbi.nlm.nih.gov/pubmed/36092216
http://dx.doi.org/10.4103/ijd.ijd_787_21
work_keys_str_mv AT canbilgen detectionofthesafezoneforuppereyelidhyaluronicacidinjections
AT betulgozel detectionofthesafezoneforuppereyelidhyaluronicacidinjections